As of 2024-12-11, the Relative Valuation of Vertex Pharmaceuticals Inc (VRTX) is 211.92 USD. This relative valuation is based on P/E multiples. With the latest stock price at 469.22 USD, the upside of Vertex Pharmaceuticals Inc based on Relative Valuation is -54.8%.
The range of the Relative Valuation is (40.99) - 641.16 USD.
| Range | Selected | |
| Trailing P/E multiples | 22.0x - 29.3x | 24.0x |
| Forward P/E multiples | 25.7x - 39.8x | 29.1x |
| Fair Price | (40.99) - 641.16 | 211.92 |
| Upside | -108.7% - 36.6% | -54.8% |
| Date | P/E |
| 2024-12-09 | -254.41 |
| 2024-12-06 | -248.03 |
| 2024-12-05 | -246.86 |
| 2024-12-04 | -249.04 |
| 2024-12-03 | -245.28 |
| 2024-12-02 | -249.98 |
| 2024-11-29 | -251.27 |
| 2024-11-27 | -249.35 |
| 2024-11-26 | -250.70 |
| 2024-11-25 | -247.82 |
| 2024-11-22 | -242.06 |
| 2024-11-21 | -241.73 |
| 2024-11-20 | -242.20 |
| 2024-11-19 | -240.47 |
| 2024-11-18 | -250.67 |
| 2024-11-15 | -249.96 |
| 2024-11-14 | -259.76 |
| 2024-11-13 | -265.48 |
| 2024-11-12 | -263.00 |
| 2024-11-11 | -269.30 |
| 2024-11-08 | -277.36 |
| 2024-11-07 | -269.69 |
| 2024-11-06 | -264.96 |
| 2024-11-05 | -268.31 |
| 2024-11-04 | -253.77 |
| 2024-11-01 | -252.87 |
| 2024-10-31 | -255.48 |
| 2024-10-30 | -255.00 |
| 2024-10-29 | -252.46 |
| 2024-10-28 | -255.69 |
| 2024-10-25 | -256.40 |
| 2024-10-24 | -253.30 |
| 2024-10-23 | -252.30 |
| 2024-10-22 | -254.91 |
| 2024-10-21 | -256.61 |
| 2024-10-18 | -259.25 |
| 2024-10-17 | -267.69 |
| 2024-10-16 | -261.53 |
| 2024-10-15 | -259.95 |
| 2024-10-14 | -260.22 |
| 2024-10-11 | -258.56 |
| 2024-10-10 | -255.57 |
| 2024-10-09 | -251.18 |
| 2024-10-08 | -246.33 |
| 2024-10-07 | -240.78 |
| 2024-10-04 | -244.39 |
| 2024-10-03 | -243.44 |
| 2024-10-02 | -248.05 |
| 2024-10-01 | -252.14 |
| 2024-09-30 | -249.63 |